Previous studies have reported that CD24 is overexpressed in nearly 70% of human cancers, and intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation21. Here, CDKN2A is linked to cancer.